Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Skin Elements Limited ( (AU:SKN) ) has provided an announcement.
Skin Elements Limited has completed the allotment of 1,092,500,000 fully paid ordinary shares as part of a two-tranche placement, with an additional 500,000,000 shares allotted to a director and senior executive following shareholder approval. This strategic move, managed by 62 Capital Pty Ltd, is expected to bolster the company’s capital structure, potentially enhancing its market position and operational capabilities in the biotechnology sector.
More about Skin Elements Limited
Skin Elements Limited is an Australian biotechnology healthcare company listed on the ASX, specializing in the commercialization of the anti-microbial SE Formula through a variety of natural and organic healthcare products. The company’s innovative approach focuses on plant-based and organic personal care and skincare products, offering a portfolio that includes hospital-grade disinfectants, bio-stimulants, natural sanitizers, and therapeutic skincare products.
Current Market Cap: A$13.8M
Find detailed analytics on SKN stock on TipRanks’ Stock Analysis page.